angiotensin ii, des-phe(8)- has been researched along with diminazene in 22 studies
| Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (diminazene) | Trials (diminazene) | Recent Studies (post-2010) (diminazene) |
|---|---|---|---|---|---|
| 1,533 | 21 | 995 | 758 | 24 | 244 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (59.09) | 24.3611 |
| 2020's | 9 (40.91) | 2.80 |
| Authors | Studies |
|---|---|
| Joseph, JP; Katovich, MJ; Mecca, AP; O'Connor, TE; Raizada, MK; Regenhardt, RW; Sumners, C | 1 |
| Batlle, D; Haber, PK; Haque, SK; Maier, C; Wysocki, J; Ye, M | 1 |
| Costa-Fraga, FP; da Silva, RF; Faye, Y; Fraga-Silva, RA; Mach, F; Montecucco, F; Pelli, G; Raizada, MK; Santos, RA; Shenoy, V; Stergiopulos, N; Sturny, M | 1 |
| Cheang, WS; Huang, Y; Lan, HY; Lau, CW; Liu, J; Luo, JY; Raizada, MK; Tian, XY; Wang, L; Wong, CM; Wong, WT; Xu, J; Yao, X; Zhang, Y | 1 |
| Baker, MB; Castellano, RK; Guo, L; Jarajapu, YP; Joshi, S; Li, Y; Raizada, MK; Singh, N | 1 |
| Červenka, L; Červenková, L; Doleželová, Š; Husková, Z; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Nishiyama, A; Sadowski, J; Škaroupková, P; Vaňourková, Z | 1 |
| Araújo, TS; Cerqueira, GS; Costa, DS; Martins, CS; Medeiros, JV; Nicolau, LA; Pacífico, DM; Silva, RO; Sousa, FB; Sousa, NA; Souza, FM; Souza, LK; Souza, MH | 1 |
| Abd El-Rahman, SS; Abdelkader, NF; Emara, M; Kamel, AS; Khattab, MM; Zaki, HF | 1 |
| Li, SM; Liu, F; Wang, XY; Yang, XH | 1 |
| Bruce, EB; Carter, CS; Kirichenko, N; Morgan, D; Sakarya, Y; Scarpace, PJ; Sumners, C; Toklu, HZ; Tümer, N | 1 |
| da Silva Filha, R; de Almeida, TCS; de Andrade De Maria, ML; Ferreira, AJ; Kangussu, LM; Prestes, TRR; Silva, ACSE; Vieira, MAR | 1 |
| Fang, Y; Gao, F; Liu, Z | 1 |
| Bessa, ASM; Biancardi, MF; Castro, CH; Colugnati, DB; Costa, JM; Dos Santos, FCA; Jesus, ÉF; Lacerda, IS; Lino-Júnior, RS; Mazaro-Costa, R; Mendes, EP; Nunes, ADC; Pedrino, GR; Pontes, CNR; Souza, EJ | 1 |
| Fujita, M; Hung, WY; Nakagawa, K; Nakagawasai, O; Nemoto, W; Tadano, T; Tan-No, K; Yamagata, R | 1 |
| Elgazzar, EM; Hasan, HF; Mostafa, DM | 1 |
| Caldas, IS; Diniz, LF; Gonçalves, RV; Gonçalves-Santos, E; Mazzeti, AL; Novaes, RD; Souza-Silva, TG; Vilas-Boas, DF | 1 |
| Duan, R; E, Y; Gong, PY; Jiang, T; Wang, SY; Xue, X; Zhang, QQ; Zhang, YD | 1 |
| Correa, AMB; de Almeida, JFQ; Ferreira, AJ; Fontes, MAP; Kushmerick, C; Moreira, FA; Patel, KP; Sharma, NM; Silva, CC | 1 |
| Gaikwad, AB; Sharma, N | 1 |
| Chai, CY; Chen, IC; Dai, ZK; Hsu, JH; Lin, JY; Liu, YC; Wu, BN; Yeh, JL | 1 |
| Białas, M; Bujak-Giżycka, B; Jawień, J; Kiepura, A; Kuś, K; Olszanecki, R; Stachowicz, A; Stachyra, K; Suski, M; Totoń-Żurańska, J; Wiśniewska, A; Łomnicka, M | 1 |
| Gupta, S; Hanif, K; Mishra, A; Shukla, S; Tiwari, P; Tiwari, V | 1 |
22 other study(ies) available for angiotensin ii, des-phe(8)- and diminazene
| Article | Year |
|---|---|
Cerebroprotection by angiotensin-(1-7) in endothelin-1-induced ischaemic stroke.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Endothelin-1; Enzyme Activation; Infarction, Middle Cerebral Artery; Male; Nitric Oxide Synthase Type II; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Stroke | 2011 |
Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Diminazene; Disease Models, Animal; Glutamyl Aminopeptidase; Hypertension; Imidazoles; In Vitro Techniques; Kidney; Leucine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Xanthones | 2014 |
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Diminazene; Down-Regulation; Erectile Dysfunction; Hypercholesterolemia; Male; Mice; Mice, Knockout; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type III; Penile Erection; Penis; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species | 2015 |
Upregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.
Topics: Acetylcholine; Aged; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Aorta; Cells, Cultured; Diabetes Mellitus, Type 2; Diminazene; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred C57BL; Middle Aged; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Reactive Oxygen Species; Renal Artery; Up-Regulation; Vasodilator Agents | 2015 |
ACE2/Ang-(1-7)/Mas axis stimulates vascular repair-relevant functions of CD34+ cells.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Antigens, CD34; Cell Adhesion; Cell Movement; Cell Proliferation; Diminazene; Humans; Leukocytes, Mononuclear; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, G-Protein-Coupled; Vasoconstrictor Agents; Vasodilator Agents; Wound Healing; Xanthones | 2015 |
Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Topics: Albuminuria; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Body Weight; Cytochrome P-450 CYP1A1; Diminazene; Enzyme Activators; Gene Expression Regulation; Hypertension, Malignant; Kidney; Mice; Peptide Fragments; Peptides; Peptidyl-Dipeptidase A; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Sodium | 2016 |
Diminazene aceturate, an angiotensin-converting enzyme II activator, prevents gastric mucosal damage in mice: Role of the angiotensin-(1-7)/Mas receptor axis.
Topics: Acetic Acid; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Ethanol; Female; Gastric Mucosa; Male; Mice; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Signal Transduction; Stomach Ulcer | 2016 |
Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway.
Topics: Alzheimer Disease; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apoptosis; Cell Survival; Cognition; Diminazene; Female; Galactose; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Maze Learning; Nerve Growth Factors; Neuronal Plasticity; Organelle Biogenesis; Ovariectomy; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats, Wistar; Receptors, G-Protein-Coupled; Receptors, Glutamate; Receptors, Nicotinic; Signal Transduction; tau Proteins | 2018 |
[ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Hindlimb; Male; Mice; Mice, Inbred ICR; Mice, Transgenic; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Reperfusion Injury | 2018 |
ACE2 activator diminazene aceturate reduces adiposity but preserves lean mass in young and old rats.
Topics: Adiposity; Age Factors; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Gene Expression; Male; Obesity; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred F344; Renin-Angiotensin System | 2018 |
Beneficial Effects of the Angiotensin-Converting Enzyme 2 Activator Dize in Renovascular Hypertension.
Topics: Acetylglucosaminidase; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Cytokines; Diminazene; Enzyme Activators; Hypertension, Renovascular; Inflammation; Kidney; Male; Nitric Oxide; Peptide Fragments; Peptidyl-Dipeptidase A; Peroxidase; Rats, Wistar; Renin-Angiotensin System | 2019 |
Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Bronchoalveolar Lavage Fluid; Diminazene; Hyperoxia; Imidazoles; Leucine; Lung Injury; Male; Mice; Mice, Inbred BALB C; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A | 2019 |
Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Blood Pressure; Cardiovascular Diseases; Diminazene; Enzyme Activators; Female; Heart; Hypertension, Pregnancy-Induced; Kidney; Male; Myocardial Contraction; Peptide Fragments; Peptidyl-Dipeptidase A; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Ventricular Function, Left | 2019 |
Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Formaldehyde; Humans; Injections, Spinal; Male; Mice; Microglia; Neurons; Nociception; p38 Mitogen-Activated Protein Kinases; Pain; Peptide Fragments; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Spinal Cord | 2020 |
Diminazene aceturate extenuate the renal deleterious consequences of angiotensin-II induced by γ-irradiation through boosting ACE2 signaling cascade.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Gamma Rays; Glutathione; Male; Oxidative Stress; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Superoxide Dismutase | 2020 |
Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study.
Topics: Angiotensin I; Animals; Cell Line; Chagas Cardiomyopathy; Chagas Disease; Diminazene; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; Myositis; Peptide Fragments; Rats; Renin-Angiotensin System; Trypanocidal Agents | 2020 |
ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Brain Chemistry; Cognitive Dysfunction; Cytokines; Diminazene; Infusions, Parenteral; Male; Maze Learning; Mice; Mice, Neurologic Mutants; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; tau Proteins | 2020 |
Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Basolateral Nuclear Complex; Diminazene; Glutamic Acid; Heart Rate; Neurons; Peptide Fragments; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Tachycardia | 2020 |
Ameliorative effect of AT2R and ACE2 activation on ischemic renal injury associated cardiac and hepatic dysfunction.
Topics: Acute Kidney Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus, Experimental; Diminazene; Imidazoles; Ischemia; Kidney; Liver; Male; Myocardium; Oxidative Stress; Peptide Fragments; Peroxidase; Rats, Wistar; Receptor, Angiotensin, Type 2; Sulfonamides; Thiophenes | 2020 |
The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Disease Models, Animal; Drug Evaluation, Preclinical; Enzyme Activators; Humans; Hypertension, Pulmonary; Peptide Fragments; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Ventricular Dysfunction, Left | 2020 |
Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Apolipoproteins E; Atherosclerosis; Diet, High-Fat; Diminazene; Disease Models, Animal; Fatty Liver; Female; Gene Expression Regulation; Humans; Liver; Macrophage Activation; Macrophages; Mesenteric Arteries; Mice; Mice, Inbred C57BL; Mice, Knockout, ApoE; Peptide Fragments; Plaque, Atherosclerotic; Taurine; THP-1 Cells | 2021 |
Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson's Disease.
Topics: Angiotensin I; Angiotensin-Converting Enzyme 2; Animals; Diminazene; Mice; Models, Theoretical; Oxidopamine; Parkinson Disease; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Rats; Receptors, G-Protein-Coupled; Signal Transduction | 2022 |